QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 0.0392
-- x --
-- x --
-- - --
$ 0.02 - $ 0.18
141,710
na
3.92M
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2023 09-30-2023 10-Q
2 08-11-2023 06-30-2023 10-Q
3 05-11-2023 03-31-2023 10-Q
4 03-27-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-28-2022 12-31-2021 10-K
9 11-12-2021 09-30-2021 10-Q
10 08-12-2021 06-30-2021 10-Q
11 05-13-2021 03-31-2021 10-Q
12 03-26-2021 12-31-2020 10-K
13 11-13-2020 09-30-2020 10-Q
14 08-14-2020 06-30-2020 10-Q
15 05-15-2020 03-31-2020 10-Q
16 03-18-2020 12-31-2019 10-K
17 11-08-2019 09-30-2019 10-Q
18 08-09-2019 06-30-2019 10-Q
19 05-09-2019 03-31-2019 10-Q
20 03-15-2019 12-31-2018 10-K
21 11-09-2018 09-30-2018 10-Q
22 08-08-2018 06-30-2018 10-Q
23 05-09-2018 03-31-2018 10-Q
24 03-15-2018 12-31-2017 10-K
25 11-09-2017 09-30-2017 10-Q
26 08-09-2017 06-30-2017 10-Q
27 05-10-2017 03-31-2017 10-Q
28 03-31-2017 12-31-2016 10-K
29 11-09-2016 09-30-2016 10-Q
30 08-11-2016 06-30-2016 10-Q
31 05-16-2016 03-31-2016 10-Q
32 03-23-2016 12-31-2015 10-K
33 11-09-2015 09-30-2015 10-Q
34 08-10-2015 06-30-2015 10-Q
35 05-11-2015 03-31-2015 10-Q
36 03-16-2015 12-31-2014 10-K
37 11-10-2014 09-30-2014 10-Q
38 08-11-2014 06-30-2014 10-Q
39 05-09-2014 03-31-2014 10-Q
40 03-14-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-femasys-shares-are-trading-higher-by-over-200-here-are-20-stocks-moving-premarket

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) cl...

 why-terran-orbital-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

 why-eiger-biopharmaceuticals-shares-are-trading-lower-by-52-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice fr...

 why-apellis-pharmaceuticals--shares-are-trading-lower-by-around-19-here-are-other-stocks-moving-in-mondays-session

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, acc...

 why-navidea-biopharmaceuticals-shares-are-nosediving

Navidea Biopharmaceuticals Inc (NASDAQ: NAVB) shares are trading lower by 18.5% to $0.08 after the company announced NYSE Ameri...

 navidea-biopharmaceuticals-inc-presses-ahead-embraces-opportunities

Following the Company's Fix, Fund, Propel approach, Navidea continues forward-focus to advance innovative technology to mar...

 why-china-natural-resources-shares-are-trading-higher-by-around-64-here-are-20-stocks-moving-premarket

Gainers

 why-coursera-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket

Gainers Unique Fabricating, Inc. (NASDAQ: UFAB) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Th...

 navidea-biopharmaceuticals-names-craig-a-dais--as-cfo

Craig A. Dais will report directly to the Company's Chief Medical Officer. Dais's hiring aligns with the Company's ...

 navidea-biopharmaceuticals-rejects-unsolicited-offer-from-prophase-labs-to-acquire-certain-assets

Following the Company's Fix, Fund, Propel approach, the proposal substantially undervalues Navidea and is not in the best i...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION